Thermage (THRM) Reports Q3 Loss of $0.03, Misses by 2c; Withdraws FY Outlook
Thermage (Nasdaq: THRM) reports Q3 loss of $0.03, 2 cents lower than the analyst estimate of ($0.01). Revenue for the quarter was $13 million, versus the consensus of $14.36 million.
Withdraws full year forecast.
Thermage, Inc. engages in the design, development, manufacture, and marketing of radiofrequency-based equipment and disposable products for non-invasive treatment of wrinkles in the United States and internationally.
Withdraws full year forecast.
Thermage, Inc. engages in the design, development, manufacture, and marketing of radiofrequency-based equipment and disposable products for non-invasive treatment of wrinkles in the United States and internationally.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Rue21, Inc. (RUE) Tops Q1 EPS by 3c; Boosts FY12 EPS Outlook; Approves $50M Buyback
- Patterson Companies, Inc. (PDCO) Tops Q4 EPS by 5c; Guides FY12
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
